{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:40:50Z","timestamp":1793400050547,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00404-020-05821-x","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T15:02:49Z","timestamp":1601996569000},"page":"37-45","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Non-antibiotic treatment of bacterial vaginosis\u2014a systematic review"],"prefix":"10.1007","volume":"303","author":[{"given":"Fiona Damaris","family":"Tidbury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Langhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Weidlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5591-1552","authenticated-orcid":false,"given":"Petra","family":"Stute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"issue":"5","key":"5821_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1471-0528.2010.02840.x","volume":"118","author":"R Lamont","year":"2011","unstructured":"Lamont R, Sobel J, Akins R et al (2011) The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG 118(5):533\u2013549. https:\/\/doi.org\/10.1111\/j.1471-0528.2010.02840.x","journal-title":"BJOG"},{"key":"5821_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00081","author":"MI Petrova","year":"2015","unstructured":"Petrova MI, Lievens E, Malik S, Imholz N, Lebeer S (2015) Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2015.00081","journal-title":"Front Physiol"},{"issue":"1","key":"5821_CR3","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/1471-2164-11-488","volume":"11","author":"XZ Ling","year":"2010","unstructured":"Ling XZ, Kong MJ, Liu F et al (2010) Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics 11(1):488. https:\/\/doi.org\/10.1186\/1471-2164-11-488","journal-title":"BMC Genomics"},{"issue":"6","key":"5821_CR4","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ajog.2013.05.006","volume":"209","author":"C Kenyon","year":"2013","unstructured":"Kenyon C, Colebunders R, Crucitti T (2013) The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol 209(6):505\u2013523. https:\/\/doi.org\/10.1016\/j.ajog.2013.05.006","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"5821_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0002-9343(83)91112-9","volume":"74","author":"R Amsel","year":"1983","unstructured":"Amsel R, Totten PA, Spiegel CA, Chen KCS, Eschenbach D, Holmes KK (1983) Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74(1):14\u201322. https:\/\/doi.org\/10.1016\/0002-9343(83)91112-9","journal-title":"Am J Med"},{"key":"5821_CR6","doi-asserted-by":"crossref","unstructured":"Nugent RP, Krohn MA, Hillier SL (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. Journal of clinical microbiology. 29(2):297\u2013301. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1706728. Accessed March 13, 2020.","DOI":"10.1128\/jcm.29.2.297-301.1991"},{"issue":"1","key":"5821_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/1471-0528.14209","volume":"124","author":"D Nasioudis","year":"2017","unstructured":"Nasioudis D, Linhares I, Ledger W, Witkin S (2017) Bacterial vaginosis: a critical analysis of current knowledge. BJOG 124(1):61\u201369. https:\/\/doi.org\/10.1111\/1471-0528.14209","journal-title":"BJOG"},{"issue":"2","key":"5821_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1128\/CMR.00075-15","volume":"29","author":"AB Onderdonk","year":"2016","unstructured":"Onderdonk AB, Delaney ML, Fichorova RN (2016) The human microbiome during bacterial vaginosis. Clin Microbiol Rev 29(2):223\u2013238. https:\/\/doi.org\/10.1128\/CMR.00075-15","journal-title":"Clin Microbiol Rev"},{"key":"5821_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejogrb.2019.12.035","volume":"245","author":"MS Coudray","year":"2020","unstructured":"Coudray MS, Madhivanan P (2020) Bacterial vaginosis\u2014A brief synopsis of the literature. Eur J Obstet Gynecol Reprod Biol 245:143\u2013148. https:\/\/doi.org\/10.1016\/j.ejogrb.2019.12.035","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"13","key":"5821_CR10","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1177\/0956462418785451","volume":"29","author":"J Sherrard","year":"2018","unstructured":"Sherrard J, Wilson J, Donders G, Mendling W, Jensen JS (2018) 2018 European (IUSTI\/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int J STD AIDS 29(13):1258\u20131272. https:\/\/doi.org\/10.1177\/0956462418785451","journal-title":"Int J STD AIDS"},{"issue":"11","key":"5821_CR11","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1086\/503780","volume":"193","author":"CS Bradshaw","year":"2006","unstructured":"Bradshaw CS, Morton AN, Hocking J et al (2006) High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 193(11):1478\u20131486. https:\/\/doi.org\/10.1086\/503780","journal-title":"J Infect Dis"},{"issue":"6","key":"5821_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1097\/GCO.0000000000000112","volume":"26","author":"CR Kenyon","year":"2014","unstructured":"Kenyon CR, Osbak K (2014) Recent progress in understanding the epidemiology of bacterial vaginosis. Curr Opin Obstet Gynecol 26(6):448\u2013454. https:\/\/doi.org\/10.1097\/GCO.0000000000000112","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"9","key":"5821_CR13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1089\/jwh.2006.15.1053","volume":"15","author":"JM Marrazzo","year":"2006","unstructured":"Marrazzo JM, Cook RL, Wiesenfeld HC et al (2006) Women\u2019s satisfaction with an intravaginal lactobacillus capsule for the treatment of bacterial vaginosis. J Women\u2019s Health 15(9):1053\u20131060. https:\/\/doi.org\/10.1089\/jwh.2006.15.1053","journal-title":"J Women\u2019s Health"},{"issue":"1","key":"5821_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejogrb.2012.12.031","volume":"168","author":"G Vujic","year":"2013","unstructured":"Vujic G, Jajac Knez A, Despot Stefanovic V, Kuzmic VV (2013) Efficacy of orally applied probiotic capsules for bacterial vaginosis and other vaginal infections: a double-blind, randomized, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 168(1):75\u201379. https:\/\/doi.org\/10.1016\/j.ejogrb.2012.12.031","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"5821_CR15","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1097\/MCG.0000000000000226","volume":"48","author":"F Vicariotto","year":"2014","unstructured":"Vicariotto F, Mogna L, del Piano M (2014) Effectiveness of the two microorganisms lactobacillus fermentum LF15 and lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis. J Clin Gastroenterol 48:S106\u2013S112. https:\/\/doi.org\/10.1097\/MCG.0000000000000226","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"5821_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1469-0691.2008.02112.x","volume":"15","author":"P Mastromarino","year":"2009","unstructured":"Mastromarino P, Macchia S, Meggiorini L et al (2009) Effectiveness of lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis. Clin Microbiol Infect 15(1):67\u201374. https:\/\/doi.org\/10.1111\/j.1469-0691.2008.02112.x","journal-title":"Clin Microbiol Infect"},{"key":"5821_CR17","doi-asserted-by":"crossref","unstructured":"Hall\u00e9n A, Jarstrand C, P\u00e5hlson C. Treatment of bacterial vaginosis with lactobacilli. Sexually transmitted diseases. 19(3):146\u2013148. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1523530. Accessed July 11, 2019.","DOI":"10.1097\/00007435-199205000-00007"},{"issue":"3","key":"5821_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00248-012-0154-3","volume":"65","author":"Z Ling","year":"2013","unstructured":"Ling Z, Liu X, Chen W et al (2013) The restoration of the vaginal microbiota after treatment for bacterial vaginosis with metronidazole or probiotics. Microb Ecol 65(3):773\u2013780. https:\/\/doi.org\/10.1007\/s00248-012-0154-3","journal-title":"Microb Ecol"},{"issue":"12\u201313","key":"5821_CR19","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1016\/j.micinf.2006.08.008","volume":"8","author":"KC Anukam","year":"2006","unstructured":"Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, Reid G (2006) Clinical study comparing probiotic lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 8(12\u201313):2772\u20132776. https:\/\/doi.org\/10.1016\/j.micinf.2006.08.008","journal-title":"Microbes Infect"},{"issue":"1","key":"5821_CR20","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000057731","volume":"204","author":"G Wewalka","year":"2002","unstructured":"Wewalka G, Stary A, Bosse B, Duerr HE, Reimer K (2002) Efficacy of povidone-iodine vaginal suppositories in the treatment of bacterial vaginosis. Dermatology 204(1):79\u201385. https:\/\/doi.org\/10.1159\/000057731","journal-title":"Dermatology"},{"issue":"11","key":"5821_CR21","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1007\/s10096-012-1671-1","volume":"31","author":"R Hemalatha","year":"2012","unstructured":"Hemalatha R, Mastromarino P, Ramalaxmi BA, Balakrishna N, v., Sesikeran B, (2012) Effectiveness of vaginal tablets containing lactobacilli versus pH tablets on vaginal health and inflammatory cytokines: a randomized, double-blind study. Eur J Clin Microbiol Infect Dis 31(11):3097\u20133105. https:\/\/doi.org\/10.1007\/s10096-012-1671-1","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"5821_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000293556","volume":"28","author":"B Fredricsson","year":"1989","unstructured":"Fredricsson B, Englund K, Weintraub L, \u00d6lund A, Nord C-E (1989) Bacterial vaginosis is not a simple ecological disorder. Gynecol Obstet Invest 28(3):156\u2013160. https:\/\/doi.org\/10.1159\/000293556","journal-title":"Gynecol Obstet Invest"},{"key":"5821_CR23","unstructured":"Parent D, Bossens M, Bayot D, et al (1996) Therapy of bacterial vaginosis using exogenously-applied lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial. Arzneimittel-Forschung. 46(1):68\u201373. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8821521. Accessed July 11, 2019."},{"issue":"4","key":"5821_CR24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1159\/000314016","volume":"70","author":"GGG Donders","year":"2010","unstructured":"Donders GGG, van Bulck B, van de Walle P et al (2010) Effect of lyophilized lactobacilli and 003 mg estriol (Gynoflor\u00ae) on vaginitis and vaginosis with disrupted vaginal microflora: a multicenter, randomized, single-blind, active-controlled pilot study. Gynecol Obstet Investig 70(4):264\u2013272. https:\/\/doi.org\/10.1159\/000314016","journal-title":"Gynecol Obstet Investig"},{"issue":"1","key":"5821_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3920\/BM2018.0075","volume":"10","author":"R Russo","year":"2019","unstructured":"Russo R, Karadja E, de Seta F (2019) Evidence-based mixture containing lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial. Benef Microbes 10(1):19\u201326. https:\/\/doi.org\/10.3920\/BM2018.0075","journal-title":"Benef Microbes"},{"issue":"1","key":"5821_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3920\/BM2017.0018","volume":"9","author":"C Laue","year":"2018","unstructured":"Laue C, Papazova E, Liesegang A et al (2018) Effect of a yoghurt drink containing lactobacillus strains on bacterial vaginosis in women\u2014a double-blind, randomised, controlled clinical pilot trial. Benef Microbes 9(1):35\u201350. https:\/\/doi.org\/10.3920\/BM2017.0018","journal-title":"Benef Microbes"},{"issue":"1","key":"5821_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12905-015-0246-6","volume":"15","author":"PB Heczko","year":"2015","unstructured":"Heczko PB, Tomusiak A, Adamski P et al (2015) Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial. BMC Women\u2019s Health 15(1):115. https:\/\/doi.org\/10.1186\/s12905-015-0246-6","journal-title":"BMC Women\u2019s Health"},{"issue":"3","key":"5821_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ijgo.2010.07.008","volume":"111","author":"R Hummelen","year":"2010","unstructured":"Hummelen R, Changalucha J, Butamanya NL, Cook A, Habbema JDF, Reid G (2010) Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV. Int J Gynecol Obstet 111(3):245\u2013248. https:\/\/doi.org\/10.1016\/j.ijgo.2010.07.008","journal-title":"Int J Gynecol Obstet"},{"issue":"2","key":"5821_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1139\/W08-102","volume":"55","author":"RCR Martinez","year":"2009","unstructured":"Martinez RCR, Franceschini SA, Patta MC et al (2009) Improved cure of bacterial vaginosis with single dose of tinidazole (2 g) Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial. Can J Microbiol 55(2):133\u2013138. https:\/\/doi.org\/10.1139\/W08-102","journal-title":"Can J Microbiol"},{"issue":"6","key":"5821_CR30","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.micinf.2006.01.003","volume":"8","author":"K Anukam","year":"2006","unstructured":"Anukam K, Osazuwa E, Ahonkhai I et al (2006) Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial. Microbes Infect 8(6):1450\u20131454. https:\/\/doi.org\/10.1016\/j.micinf.2006.01.003","journal-title":"Microbes Infect"},{"issue":"4","key":"5821_CR31","doi-asserted-by":"publisher","first-page":"e34540","DOI":"10.1371\/journal.pone.0034540","volume":"7","author":"CS Bradshaw","year":"2012","unstructured":"Bradshaw CS, Pirotta M, de Guingand D et al (2012) Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial. PLoS ONE 7(4):e34540. https:\/\/doi.org\/10.1371\/journal.pone.0034540","journal-title":"PLoS ONE"},{"issue":"2","key":"5821_CR32","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000293230","volume":"30","author":"B Andersch","year":"1990","unstructured":"Andersch B, Lindell D, Dahl\u00e9n I, Brandberg \u00c5 (1990) Bacterial vaginosis and the effect of intermittent prophylactic treatment with an acid lactate gel. Gynecol Obstet Invest 30(2):114\u2013119. https:\/\/doi.org\/10.1159\/000293230","journal-title":"Gynecol Obstet Invest"},{"issue":"1","key":"5821_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000298923","volume":"21","author":"B Andersch","year":"1986","unstructured":"Andersch B, Forssman L, Lincoln K, Torstensson P (1986) Treatment of bacterial vaginosis with an acid cream: a comparison between the effect of lactate-gel and metronidazole. Gynecol Obstet Invest 21(1):19\u201325. https:\/\/doi.org\/10.1159\/000298923","journal-title":"Gynecol Obstet Invest"},{"issue":"2","key":"5821_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1447-0756.2006.00383.x","volume":"32","author":"DCD Decena","year":"2006","unstructured":"Decena DCD, Co JT, Manalastas RM et al (2006) Metronidazole with lactacyd vaginal gel in bacterial vaginosis. J Obstet Gynaecol Res 32(2):243\u2013251. https:\/\/doi.org\/10.1111\/j.1447-0756.2006.00383.x","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"5821_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/sti.69.5.388","volume":"69","author":"AJ Boeke","year":"1993","unstructured":"Boeke AJ, Dekker JH, van Eijk JT, Kostense PJ, Bezemer PD (1993) Effect of lactic acid suppositories compared with oral metronidazole and placebo in bacterial vaginosis: a randomised clinical trial. Sex Transm Infect 69(5):388\u2013392. https:\/\/doi.org\/10.1136\/sti.69.5.388","journal-title":"Sex Transm Infect"},{"issue":"1","key":"5821_CR36","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1186\/s13063-018-2905-z","volume":"19","author":"S Khazaeian","year":"2018","unstructured":"Khazaeian S, Navidian A, Navabi-Rigi S, Araban M, Mojab F, Khazaeian S (2018) Comparing the effect of sucrose gel and metronidazole gel in treatment of clinical symptoms of bacterial vaginosis: a randomized controlled trial. Trials 19(1):585. https:\/\/doi.org\/10.1186\/s13063-018-2905-z","journal-title":"Trials"},{"issue":"2","key":"5821_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jogoh.2017.11.005","volume":"47","author":"JM Bohbot","year":"2018","unstructured":"Bohbot JM, Dara\u00ef E, Bretelle F, Brami G, Daniel C, Cardot JM (2018) Efficacy and safety of vaginally administered lyophilized Lactobacillus crispatus IP 174178 in the prevention of bacterial vaginosis recurrence. J Gynecol Obstet Hum Reprod 47(2):81\u201386. https:\/\/doi.org\/10.1016\/j.jogoh.2017.11.005","journal-title":"J Gynecol Obstet Hum Reprod"},{"issue":"12","key":"5821_CR38","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/OLQ.0b013e3181e50026","volume":"37","author":"A Hemmerling","year":"2010","unstructured":"Hemmerling A, Harrison W, Schroeder A et al (2010) Phase 2a study assessing colonization efficiency, safety, and acceptability of lactobacillus crispatus CTV-05 in women with bacterial vaginosis. Sex Transm Dis 37(12):745\u2013750. https:\/\/doi.org\/10.1097\/OLQ.0b013e3181e50026","journal-title":"Sex Transm Dis"},{"issue":"10","key":"5821_CR39","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.micinf.2010.04.010","volume":"12","author":"S Ehrstr\u00f6m","year":"2010","unstructured":"Ehrstr\u00f6m S, Daroczy K, Rylander E et al (2010) Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis. Microbes Infect 12(10):691\u2013699. https:\/\/doi.org\/10.1016\/j.micinf.2010.04.010","journal-title":"Microbes Infect"},{"issue":"1","key":"5821_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-6874-8-3","volume":"8","author":"P-G Larsson","year":"2008","unstructured":"Larsson P-G, Stray-Pedersen B, Ryttig KR, Larsen S (2008) Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Women\u2019s Health 8(1):3. https:\/\/doi.org\/10.1186\/1472-6874-8-3","journal-title":"BMC Women\u2019s Health"},{"issue":"1","key":"5821_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/00015550410022249","volume":"85","author":"K Eriksson","year":"2005","unstructured":"Eriksson K, Carlsson B, Forsum U, Larsson P-G (2005) A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open treatment with vaginal clindamycin ovules. Acta Dermato-Venereologica 85(1):42\u201346. https:\/\/doi.org\/10.1080\/00015550410022249","journal-title":"Acta Dermato-Venereologica"},{"issue":"3","key":"5821_CR42","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ijgo.2010.04.025","volume":"110","author":"V Marcone","year":"2010","unstructured":"Marcone V, Rocca G, Lichtner M, Calzolari E (2010) Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis. Int J Gynecol Obstet 110(3):223\u2013226. https:\/\/doi.org\/10.1016\/j.ijgo.2010.04.025","journal-title":"Int J Gynecol Obstet"},{"key":"5821_CR43","unstructured":"Marcone V, Calzolari E, Bertini M (2008) Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences. The new microbiologica 31(3):429\u2013433. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18843900. Accessed July 11, 2019."},{"issue":"11","key":"5821_CR44","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/j.1471-0528.2008.01882.x","volume":"115","author":"L Petricevic","year":"2008","unstructured":"Petricevic L, Witt A (2008) The role of Lactobacillus casei rhamnosus Lcr35 in restoring the normal vaginal flora after antibiotic treatment of bacterial vaginosis. BJOG 115(11):1369\u20131374. https:\/\/doi.org\/10.1111\/j.1471-0528.2008.01882.x","journal-title":"BJOG"},{"issue":"2","key":"5821_CR45","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0928-8244(02)00465-0","volume":"35","author":"G Reid","year":"2003","unstructured":"Reid G, Charbonneau D, Erb J et al (2003) Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 35(2):131\u2013134. https:\/\/doi.org\/10.1016\/S0928-8244(02)00465-0","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"5821_CR46","doi-asserted-by":"publisher","first-page":"120.e1","DOI":"10.1016\/j.ajog.2010.05.023","volume":"203","author":"W Ya","year":"2010","unstructured":"Ya W, Reifer C, Miller LE (2010) Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study. Am J Obstet Gynecol 203(2):120.e1\u2013120.e6. https:\/\/doi.org\/10.1016\/j.ajog.2010.05.023","journal-title":"Am J Obstet Gynecol"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05821-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-020-05821-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-020-05821-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T02:29:55Z","timestamp":1633487395000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-020-05821-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["5821"],"URL":"https:\/\/doi.org\/10.1007\/s00404-020-05821-x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740687393.793592074","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.740687393.793588143","asserted-by":"object"}]},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"16 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"FDT, AL and SW declare no competing financial interests. PS has received an unrestricted grant from Schaer Pharma Service GmbH to conduct a multicenter RCT in women with BV comparing standard antibiotic treatment to a vaginal acid gel (cantonal ethic committee Bern: No. 2016_01992). The authors alone are responsible for the content and writing of the paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}